Adcentrx Therapeutics Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 30

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $51M

  • Investors
  • 9

Adcentrx Therapeutics General Information

Description

Operator of a biotechnology company intended to focus on protein conjugate therapeutics for cancer and other life-threatening diseases. The company's platform focuses on accelerating breakthroughs in protein conjugate therapeutic development for cancer and other life-threatening diseases and combines the targeting precision of biologics and the disease-fighting power of small molecule payloads, enabling patients with targeted therapies as treatment options.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 5580 Morehouse Drive
  • Suite 210
  • San Diego, CA 92121
  • United States
+1 (858)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 5580 Morehouse Drive
  • Suite 210
  • San Diego, CA 92121
  • United States
+1 (858)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Adcentrx Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A) 05-Dec-2023 $51M Completed Clinical Trials - Phase 1
1. Early Stage VC (Series A) 28-Apr-2021 Completed Clinical Trials - Phase 1
To view Adcentrx Therapeutics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Adcentrx Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biotechnology company intended to focus on protein conjugate therapeutics for cancer and other life-threat
Drug Discovery
San Diego, CA
30 As of 2025

Vancouver, Canada
 

Cambridge, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Adcentrx Therapeutics Competitors (4)

One of Adcentrx Therapeutics’s 4 competitors is Zymeworks, a Formerly VC-backed company based in Vancouver, Canada.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Zymeworks Formerly VC-backed Vancouver, Canada
Mersana Therapeutics Formerly VC-backed Cambridge, MA
Ambrx Formerly PE-Backed San Diego, CA
Tubulis Formerly VC-backed Planegg-Martinsried, Germany
To view Adcentrx Therapeutics’s complete competitors history, request access »

Adcentrx Therapeutics Patents

Adcentrx Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026198631-A2 Methods and compositions related to antibodies and antibody drug conjugates (adcs) that bind slc34a2 proteins Pending 19-Mar-2025
WO-2026198631-A3 Methods and compositions related to antibodies and antibody drug conjugates (adcs) that bind slc34a2 proteins Pending 19-Mar-2025
WO-2025264533-A1 Methods and compositions related to antibody drug conjugates (adcs) that bind steap-1 proteins Pending 17-Jun-2024
JP-2026527554-A Drug conjugates and methods of manufacturing and using the same Pending 03-Aug-2023
AU-2024316659-A1 Drug conjugates and methods of preparing and using the same Pending 03-Aug-2023 A61K47/6889
To view Adcentrx Therapeutics’s complete patent history, request access »

Adcentrx Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Adcentrx Therapeutics Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
ABio-X PE-Backed Company Minority
Delta Capital Venture Capital Minority
Eight Roads Corporate Venture Capital Minority
F-Prime Venture Capital Minority
Partners Investment Venture Capital Minority
You’re viewing 5 of 9 investors. Get the full list »

Adcentrx Therapeutics FAQs

  • When was Adcentrx Therapeutics founded?

    Adcentrx Therapeutics was founded in 2021.

  • Where is Adcentrx Therapeutics headquartered?

    Adcentrx Therapeutics is headquartered in San Diego, CA.

  • What is the size of Adcentrx Therapeutics?

    Adcentrx Therapeutics has 30 total employees.

  • What industry is Adcentrx Therapeutics in?

    Adcentrx Therapeutics’s primary industry is Drug Discovery.

  • Is Adcentrx Therapeutics a private or public company?

    Adcentrx Therapeutics is a Private company.

  • What is Adcentrx Therapeutics’s current revenue?

    The current revenue for Adcentrx Therapeutics is .

  • How much funding has Adcentrx Therapeutics raised over time?

    Adcentrx Therapeutics has raised $101M.

  • Who are Adcentrx Therapeutics’s investors?

    ABio-X, Delta Capital, Eight Roads, F-Prime, and Partners Investment are 5 of 9 investors who have invested in Adcentrx Therapeutics.

  • Who are Adcentrx Therapeutics’s competitors?

    Zymeworks, Mersana Therapeutics, Ambrx, and Tubulis are competitors of Adcentrx Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process